Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,963 | -92,732 | -78,777 | -46,113 | -22,497 |
| Depreciation Amortization | 805 | 4,414 | 3,336 | 2,258 | 1,144 |
| Accounts receivable | 661 | 10,787 | 11,651 | 11,974 | 12,245 |
| Other Working Capital | -2,884 | 8,197 | 4,329 | 3,212 | 7,301 |
| Other Operating Activity | 3,601 | 2,692 | -1,033 | -13,516 | -14,450 |
| Operating Cash Flow | $-29,780 | $-66,642 | $-60,494 | $-42,185 | $-16,257 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -325 | 676 | 763 | -25 | -13 |
| Purchase Of Investment | -25,477 | -112,615 | N/A | N/A | N/A |
| Sale Of Investment | 25,005 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 2,988 | -451 | 26 | 25 | 58 |
| Investing Cash Flow | $2,191 | $-112,390 | $789 | $N/A | $45 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -960 | -3,518 | -2,588 | -1,684 | -816 |
| Common Stock Issued | 385,256 | 248,805 | 248,329 | 81,496 | 5,267 |
| Financing Cash Flow | $384,296 | $245,287 | $245,741 | $79,812 | $4,451 |
| Exchange Rate Effect | 597 | 1,870 | 1,990 | 2,424 | 578 |
| Beginning Cash Position | 159,700 | 91,575 | 91,575 | 91,575 | 91,575 |
| End Cash Position | 517,004 | 159,700 | 279,601 | 131,626 | 80,392 |
| Net Cash Flow | $357,304 | $68,125 | $188,026 | $40,051 | $-11,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,780 | -66,642 | -60,494 | -42,185 | -16,257 |
| Capital Expenditure | -325 | -113 | -26 | -25 | -13 |
| Free Cash Flow | -30,105 | -66,755 | -60,520 | -42,210 | -16,270 |